EUVIMEDEUVIMED entdecken
Open Access

Octreotide protects against LPS-induced endothelial cell and lung injury

Saikat Fakir, Khadeja-Tul Kubra, Nektarios Barabutis

Cellular Signalling · 2024

DOI: 10.1016/j.cellsig.2024.111455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2024. Verfasst von Saikat Fakir und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA. Hauptthemen laut MEDLINE: Lipopolysaccharides, Octreotide, Endothelial Cells, Acute Lung Injury. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growth hormone (GH) is a crucial regulator of growth, cell reproduction, and regeneration; and it is controlled by growth hormone-releasing hormone (GHRH) and somatostatin. Lipopolysaccharides (LPS) can compromise endothelial function, leading to increased inflammation and vascular leak. Octreotide (OCT) is an FDA-approved synthetic somatostatin analog (SSA) used to treat acromegaly and neuroendocrine tumors. The present study investigates the effects of OCT on LPS-induced injury in bovine and human lung endothelial cells, as well as in mouse lungs. Our in vitro observations suggest that OCT effectively counteracts LPS-induced endothelial leak, inflammation, and reactive oxygen species (ROS) generation. Furthermore, OCT reduces bronchoalveolar lavage fluid (BALF) protein concentration in an experimental model of Acute Lung Injury (ALI). Our study suggests that OCT mitigates LPS-induced endothelial cell and lung injury, suggesting that it may represent an exciting therapeutic possibility in diseases related to barrier dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesOctreotideEndothelial CellsAcute Lung InjuryAnimalsHumansCattleMiceReactive Oxygen SpeciesLungMice, Inbred C57BLBronchoalveolar Lavage FluidMaleProtective Agents

Stichwörter der Autor:innen

GHRHInflammationSomatostatin

Substanzen

LipopolysaccharidesOctreotideReactive Oxygen SpeciesProtective Agents

Autor:innen und Institutionen

  • School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.
  • School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA. Electronic address: barabutis@ulm.edu.

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Fakir, S., Kubra, K. T., & Barabutis, N. (2024). Octreotide protects against LPS-induced endothelial cell and lung injury. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111455

Vancouver

Fakir S, Kubra KT, Barabutis N. Octreotide protects against LPS-induced endothelial cell and lung injury. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111455

BibTeX
@article{Fakir2024,
  author = {Fakir, Saikat and Kubra, Khadeja-Tul and Barabutis, Nektarios},
  title = {Octreotide protects against LPS-induced endothelial cell and lung injury},
  journal = {Cellular Signalling},
  year = {2024},
  doi = {10.1016/j.cellsig.2024.111455}
}
Kostenlos starten →